In world of stem cell research, ‘UC Caucus’ reigns supreme
By David Jensen,
Capitol Weekly
| 06. 21. 2021
They could be called the “UC Caucus,” although that may presume too much. Nonetheless, they come from an institution that has pulled down $1.2 billion from the California state stem cell agency, more than any other enterprise during the last 16 years.
Not to mention that their employer — the University of California — is likely to snag much, much more during the next decade or so.
The “caucus” is composed of the 13 persons with ties to the University of California (UC) who are also members of the governing board of the state’s $12 billion stem cell agency, known officially as the California Institute for Regenerative Medicine(CIRM).
The board is so large, in fact, that at times its board members have outnumbered the CIRM staff.
The UC 13 constitute the largest voting bloc on the CIRM governing board. The “caucus” includes Art Torres, who is a member of the UC Board of Regents and the salaried, vice chairman of the CIRM board of directors. Torres is a well-seasoned, former state politician with decades of vote-counting experience.
The CIRM...
Related Articles
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025
Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.
Sunday’s announcement clears the way for a new...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Frank Landymore, Futurism | 03.18.2025
You can only throw so much money at a problem.
This, more or less, is the line being taken by AI researchers in a recent survey. Asked whether "scaling up" current AI approaches could lead to achieving artificial general...
By Craig S. Smith, Forbes | 03.08.2025
One recent evening in Shenzhen, a group of software engineers gathered in a dimly lit co-working space, furiously typing as they monitored the performance of a new AI system. The air was electric, thick with the hum of servers and...
